TWST - Twist Bioscience up 16% after insider purchase

2023-05-15 12:03:23 ET

• Twist Bioscience Corporation ( NASDAQ: TWST ) added ~16% on Monday to mark the biggest intraday gain since November after its senior vice president Dennis Cho disclosed the purchase of 10K shares of the synthetic biology company.
• According to a regulatory filing on Friday, Cho, who serves as TWST’s general counsel and chief ethics and compliance officer, bought the shares last week at $13.20 apiece, increasing his stake by more than 50%.
• The transaction worth over $132K marks Twist’s ( TWST ) first insider purchase in a year and comes ahead of an industry conference in Antwerp, Belgium, where the company’s CEO Emily Leproust is scheduled to present on Wednesday.
• The presentation titled “Scaling SemiSynBio to fuel the growth towards a $1T semiconductor industry” will focus on how to drive industry growth using CMOS-based chips for high-density DNA synthesis for data storage applications.

For further details see: